Literature DB >> 7846921

Selective decontamination of the colon before elective colorectal surgery. West of Scotland Surgical Infection Study Group.

E W Taylor1, G Lindsay.   

Abstract

The controversy over the route of administration of antibiotic prophylaxis in patients undergoing elective colorectal operations persists for oral, parenteral, and a combination of the two routes. The oral antibiotics commonly administered for colorectal prophylaxis, neomycin and eythromycin base, are not absorbed in the gastrointestinal tract (GIT). However, the 4-fluoroquinolones are absorbed in the upper GIT and are excreted in part by the colonic mucosa. Their action is then to remove, or severely depress, the gram-negative aerobic bacilli leaving the anaerobic flora unaffected. This action is the principle of selective decontamination. We have assessed the efficacy of oral ciprofloxacin in a prospective randomized clinical trial in which all patients received piperacillin 4 g i.v. as single-dose parenteral prophylaxis. A group of 327 evaluable patients were randomized to receive ciprofloxacin 500 mg b.i.d. with the preoperative cathartic (group OA, n = 159) or no oral antibiotic (group NOA, n = 168). Postoperative wound infection occurred in 18 (11.3%) patients in group OA and 39 (23.2%) patients in group NOA (chi 2 = 7.2, p = 0.007). Operation-related infection of any type occurred in 23 (14.5%) patients in group OA compared with 55 (32.7%) in group NOA (chi 2 = 14.0, p = 0.0002). The median postoperative hospital stay was 11 days (interquartile range 4.5 days) for group OA and 12 days (interquartile range 8 days) for group NOA (Mann Whitney U test, p = 0.005). Ignoring the treatment group, the median postoperative hospital stay was 17 days (interquartile range 10 days) for infected patients and 11 days (interquartile range 4 days) for those not infected.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846921     DOI: 10.1007/bf00299111

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses.

Authors:  I Brook; E H Frazier
Journal:  Arch Surg       Date:  1990-11

2.  Addition of parenteral cefoxitin to regimen of oral antibiotics for elective colorectal operations. A randomized prospective study.

Authors:  D J Schoetz; P L Roberts; J J Murray; J A Coller; M C Veidenheimer
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

3.  Efficacy of preoperative antimicrobial preparation of the bowel.

Authors:  R L Nichols; R E Condon; S L Gorbach; L M Nyhus
Journal:  Ann Surg       Date:  1972-08       Impact factor: 12.969

4.  A multicentre study to compare piperacillin with the combination of netilmicin and metronidazole for prophylaxis in elective colorectal surgery undertaken in district general hospitals.

Authors:  A J Walker; E W Taylor; G Lindsay; E P Dewar
Journal:  J Hosp Infect       Date:  1988-05       Impact factor: 3.926

5.  Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery.

Authors:  M R Keighley; Y Arabi; J Alexander-Williams; D Youngs; D W Burdon
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

6.  [Infection prevention in elective large intestine surgery. Results of a prospective randomized comparative study].

Authors:  H Winker; J Dortenmann; D H Wittmann
Journal:  Chirurg       Date:  1983-04       Impact factor: 0.955

7.  Comparison between oral and systemic antibiotics and their combined use for the prevention of complications in colorectal surgery.

Authors:  F Lazorthes; G Legrand; X Monrozies; E Fretigny; G Pugnet; J A Cordova; D Vergnes; L Enjalbert
Journal:  Dis Colon Rectum       Date:  1982 May-Jun       Impact factor: 4.585

8.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

Review 9.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

10.  Veterans Administration Cooperative Study on Bowel Preparation for Elective Colorectal Operations: impact of oral antibiotic regimen on colonic flora, wound irrigation cultures and bacteriology of septic complications.

Authors:  J G Bartlett; R E Condon; S L Gorbach; J S Clarke; R L Nichols; S Ochi
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

View more
  6 in total

1.  Antimicrobial prophylaxis in colorectal surgery.

Authors:  A M Glenny; F Song
Journal:  Qual Health Care       Date:  1999-06

2.  Perioperative selective decontamination of the digestive tract (SDD) in elective colorectal surgery.

Authors:  Daphne Roos; Lea M Dijksman; Brigitte M Sondermeijer; Heleen M Oudemans-van Straaten; Laurens T de Wit; Michael F Gerhards
Journal:  J Gastrointest Surg       Date:  2009-07-28       Impact factor: 3.452

Review 3.  Selective decontamination of the digestive tract in gastrointestinal surgery: useful in infection prevention? A systematic review.

Authors:  Gabor S A Abis; Hein B A C Stockmann; Marjolein van Egmond; Hendrik J Bonjer; Christina M J E Vandenbroucke-Grauls; Steven J Oosterling
Journal:  J Gastrointest Surg       Date:  2013-10-11       Impact factor: 3.452

Review 4.  Combination of oral non-absorbable and intravenous antibiotics versus intravenous antibiotics alone in the prevention of surgical site infections after colorectal surgery: a meta-analysis of randomized controlled trials.

Authors:  C F Bellows; K T Mills; T N Kelly; G Gagliardi
Journal:  Tech Coloproctol       Date:  2011-07-23       Impact factor: 3.781

Review 5.  The prevention of surgical site infection in elective colon surgery.

Authors:  Donald E Fry
Journal:  Scientifica (Cairo)       Date:  2013-12-19

6.  The Role of Oral Antibiotic Preparation in Elective Colorectal Surgery: A Meta-analysis.

Authors:  Katie E Rollins; Hannah Javanmard-Emamghissi; Austin G Acheson; Dileep N Lobo
Journal:  Ann Surg       Date:  2019-07       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.